U.S. STOCKS Deckers Outdoor, Mohawk Industries, Insulet
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Nasdaq futures jumped 1% on Friday as megacap tech and chip stocks bounced back after a drubbing earlier this week, while investors hoped for a further let-up in inflation in a crucial data release later in the day. .N
At 7:34 ET, Dow e-minis 1YMc1 were up 0.60% at 40,435. S&P 500 e-minis ESc1 were up 0.76% at 5,482.75, while Nasdaq 100 e-minis NQc1 were up 1.05% at 19,191.5.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** Everi Holdings <EVRI.N>, up 37.4%
** Coursera <COUR.N>, up 25.9%
** International Game Technology PLC <IGT.N>, up 15.1%
The top three NYSE percentage losers premarket .PRPL.NQ:
** Carter's <CRI.N>, down 9.7%
** Olin <OLN.N>, down 8.3%
** Container Store Group <TCS.N>, down 7.5%
The top two Nasdaq percentage gainers premarket .PRPG.O:
** Windtree Therapeutics <WINT.O>, up 99.7%
** Carbon Revolution plc <CREV.O>, up 92.9%
The top Nasdaq percentage loser premarket .PRPL.O:
** Nature's Miracle Holding <NMHI.O>, down 29.8%
** Dexcom DXCM.O: down 37.1% premarket
BUZZ - Plunges after trimming FY24 revenue forecast nL4N3JI0NL
** 3M MMM.N: up 6.5% premarket
BUZZ - Rises after upbeat quarterly results, forecast raise nL4N3JI0X4
** Coursera COUR.N: up 25.9% premarket
BUZZ - Jumps on strong demand for AI courses nL4N3JI0RA
** Deckers Outdoor DECK.N: up 11.6% premarket
BUZZ - Gains as full-price selling drives profit forecast hike nL4N3JI0S6
** Boyd Gaming BYD.N: up 5.1% premarket
BUZZ - Gains after Q2 results beat estimates nL4N3JI0SP
** Karooooo KARO.O: up 12.8% premarket
BUZZ - Rises as CEO scraps stock sale nL1N3JI0AW
** Mohawk Industries MHK.N: up 14.2% premarket
BUZZ - Rises after Q2 profit beats estimates nL4N3JI0UA
** Baker Hughes BKR.O: up 1.9% premarket
BUZZ - Rises after Q2 profit beat on international market strength nL4N3JI0U9
** Insulet PODD.O: up 2.2% premarket
BUZZ - Rises on better-than-expected prelim Q2 revenue nL4N3JI0UN
** Biogen BIIB.O: down 6.0% premarket
BUZZ - Falls as EU regulator declines to recommend Alzheimer's drug nL4N3JI0WR
** Bristol Myers Squibb BMY.N: up 3.8% premarket
BUZZ - Climbs on Q2 results beat nL4N3JI0Z4
** Centene CNC.N: up 2.6% premarket
BUZZ - Up on beating Q2 profit estimates nL4N3JI0UI
** Newell Brands NWL.O: up 8.8% premarket
BUZZ - Up on annual profit forecast raise nL4N3JI0ZB
** International Game Technology PLC IGT.N: up 15.1% premarket
** Everi Holdings EVRI.N: up 37.4% premarket
BUZZ - Shares rise after Apollo Funds $6.3 bln deal nL4N3JI0Z2
(Compiled by Rajarshi Roy and Anuja Bharat Mistry in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
